Structural determinants of the eosinophil cationic protein antimicrobial activity

The sulfate-binding site structure of the human eosinophil cationic protein as revealed by a new crystal form

(2012) Ester Boix et al.   JOURNAL OF STRUCTURAL BIOLOGY

Peptide-based treatment of sepsis

(2011) Klaus Brandenburg et al.   APPLIED MICROBIOLOGY AND BIOTECHNOLOGY

Bovine Pancreatic Ribonuclease: Fifty Years of the First Enzymatic Reaction Mechanism

(2011) Claudi M. Cuchillo et al.   BIOCHEMISTRY

Biophysical Mechanisms of Endotoxin Neutralization by Cationic Amphiphilic Peptides

(2011) Yani Kaconis et al.   BIOPHYSICAL JOURNAL

Refining the Eosinophil Cationic Protein Antibacterial Pharmacophore by Rational Structure Minimization

(2011) Marc Torrent et al.   JOURNAL OF MEDICINAL CHEMISTRY

Mapping the eosinophil cationic protein antimicrobial activity by chemical and enzymatic cleavage

(2010) Daniel Sánchez et al.   BIOCHIMIE

Eosinophil Cationic Protein Aggregation: Identification of an N-Terminus Amyloid Prone Region

(2010) Marc Torrent et al.   BIOMACROMOLECULES

Eosinophil cationic protein (ECP) can bind heparin and other glycosaminoglycans through its RNase active site

(2010) Marc Torrent et al.   JOURNAL OF MOLECULAR RECOGNITION

Bactericidal Activity Engineered on Human Pancreatic Ribonuclease and Onconase†

(2009) Gerard Torrent et al.   MOLECULAR PHARMACEUTICS

The chemistry and biology of LL-37

(2009) Matthew F. Burton et al.   NATURAL PRODUCT REPORTS

Mechanisms of action of angiogenin

(2008) Xiangwei Gao et al.   ACTA BIOCHIMICA ET BIOPHYSICA SINICA

Eosinophil-Derived Neurotoxin / RNase 2: Connecting the Past, the Present and the Future

(2008) H. Rosenberg   CURRENT PHARMACEUTICAL BIOTECHNOLOGY

The Antipathogen Activities of Eosinophil Cationic Protein

(2008) Ester Boix et al.   CURRENT PHARMACEUTICAL BIOTECHNOLOGY